Autoimmune diseases is a body’s hyperactive immune response against the substances and tissues normally present in the body. Autoimmune diseases are more commonly caused by genetic, infectious or environmental factors.
The “Autoimmune Disease Treatment Industry Forecast” looks at past sales and reviews total world Autoimmune Disease Treatment sales in 2022, providing a comprehensive analysis by region and market sector of projected Autoimmune Disease Treatment sales for 2023 through 2029. With Autoimmune Disease Treatment sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Autoimmune Disease Treatment industry.
This Insight Report provides a comprehensive analysis of the global Autoimmune Disease Treatment landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Autoimmune Disease Treatment portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Autoimmune Disease Treatment market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Autoimmune Disease Treatment and breaks down the forecast by type, by sale channel, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Autoimmune Disease Treatment.
The global Autoimmune Disease Treatment market size is projected to grow from US$ 96030 million in 2022 to US$ 114070 million in 2029; it is expected to grow at a CAGR of 2.5% from 2023 to 2029.
United States market for Autoimmune Disease Treatment is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Autoimmune Disease Treatment is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Autoimmune Disease Treatment is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Autoimmune Disease Treatment players cover Abbott Laboratories, Active Biotech, Eli Lilly, Bristol-Myers Squibb, AstraZeneca plc, Pfizer, Biogen Idec, Lupin Limited and GlaxoSmithKline, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
This report presents a comprehensive overview, market shares, and growth opportunities of Autoimmune Disease Treatment market by product type, application, key players and key regions and countries.
Market Segmentation:
Segmentation by type
Immunosuppressant’s
Anti-Inflammatory Drugs
Corticosteroids
Nonsteroidal Anti-inflammatory Drugs
Biologics
Segmentation by sale channel
Hospitals
Clinics
Drug Stores
Other
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Abbott Laboratories
Active Biotech
Eli Lilly
Bristol-Myers Squibb
AstraZeneca plc
Pfizer
Biogen Idec
Lupin Limited
GlaxoSmithKline
Amgen
4SC AG
F. Hoffmann-La Roche Ltd.
AutoImmune Inc
Johnson & Johnson
Bayer
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Autoimmune Disease Treatment Market Size 2018-2029
2.1.2 Autoimmune Disease Treatment Market Size CAGR by Region 2018 VS 2022 VS 2029
2.2 Autoimmune Disease Treatment Segment by Type
2.2.1 Immunosuppressant’s
2.2.2 Anti-Inflammatory Drugs
2.2.3 Corticosteroids
2.2.4 Nonsteroidal Anti-inflammatory Drugs
2.2.5 Biologics
2.3 Autoimmune Disease Treatment Market Size by Type
2.3.1 Autoimmune Disease Treatment Market Size CAGR by Type (2018 VS 2022 VS 2029)
2.3.2 Global Autoimmune Disease Treatment Market Size Market Share by Type (2018-2023)
2.4 Autoimmune Disease Treatment Segment by Sale Channel
2.4.1 Hospitals
2.4.2 Clinics
2.4.3 Drug Stores
2.4.4 Other
2.5 Autoimmune Disease Treatment Market Size by Sale Channel
2.5.1 Autoimmune Disease Treatment Market Size CAGR by Sale Channel (2018 VS 2022 VS 2029)
2.5.2 Global Autoimmune Disease Treatment Market Size Market Share by Sale Channel (2018-2023)
3 Autoimmune Disease Treatment Market Size by Player
3.1 Autoimmune Disease Treatment Market Size Market Share by Players
3.1.1 Global Autoimmune Disease Treatment Revenue by Players (2018-2023)
3.1.2 Global Autoimmune Disease Treatment Revenue Market Share by Players (2018-2023)
3.2 Global Autoimmune Disease Treatment Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2021-2023)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 Autoimmune Disease Treatment by Regions
4.1 Autoimmune Disease Treatment Market Size by Regions (2018-2023)
4.2 Americas Autoimmune Disease Treatment Market Size Growth (2018-2023)
4.3 APAC Autoimmune Disease Treatment Market Size Growth (2018-2023)
4.4 Europe Autoimmune Disease Treatment Market Size Growth (2018-2023)
4.5 Middle East & Africa Autoimmune Disease Treatment Market Size Growth (2018-2023)
5 Americas
5.1 Americas Autoimmune Disease Treatment Market Size by Country (2018-2023)
5.2 Americas Autoimmune Disease Treatment Market Size by Type (2018-2023)
5.3 Americas Autoimmune Disease Treatment Market Size by Sale Channel (2018-2023)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Autoimmune Disease Treatment Market Size by Region (2018-2023)
6.2 APAC Autoimmune Disease Treatment Market Size by Type (2018-2023)
6.3 APAC Autoimmune Disease Treatment Market Size by Sale Channel (2018-2023)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe Autoimmune Disease Treatment by Country (2018-2023)
7.2 Europe Autoimmune Disease Treatment Market Size by Type (2018-2023)
7.3 Europe Autoimmune Disease Treatment Market Size by Sale Channel (2018-2023)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Autoimmune Disease Treatment by Region (2018-2023)
8.2 Middle East & Africa Autoimmune Disease Treatment Market Size by Type (2018-2023)
8.3 Middle East & Africa Autoimmune Disease Treatment Market Size by Sale Channel (2018-2023)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Global Autoimmune Disease Treatment Market Forecast
10.1 Global Autoimmune Disease Treatment Forecast by Regions (2024-2029)
10.1.1 Global Autoimmune Disease Treatment Forecast by Regions (2024-2029)
10.1.2 Americas Autoimmune Disease Treatment Forecast
10.1.3 APAC Autoimmune Disease Treatment Forecast
10.1.4 Europe Autoimmune Disease Treatment Forecast
10.1.5 Middle East & Africa Autoimmune Disease Treatment Forecast
10.2 Americas Autoimmune Disease Treatment Forecast by Country (2024-2029)
10.2.1 United States Autoimmune Disease Treatment Market Forecast
10.2.2 Canada Autoimmune Disease Treatment Market Forecast
10.2.3 Mexico Autoimmune Disease Treatment Market Forecast
10.2.4 Brazil Autoimmune Disease Treatment Market Forecast
10.3 APAC Autoimmune Disease Treatment Forecast by Region (2024-2029)
10.3.1 China Autoimmune Disease Treatment Market Forecast
10.3.2 Japan Autoimmune Disease Treatment Market Forecast
10.3.3 Korea Autoimmune Disease Treatment Market Forecast
10.3.4 Southeast Asia Autoimmune Disease Treatment Market Forecast
10.3.5 India Autoimmune Disease Treatment Market Forecast
10.3.6 Australia Autoimmune Disease Treatment Market Forecast
10.4 Europe Autoimmune Disease Treatment Forecast by Country (2024-2029)
10.4.1 Germany Autoimmune Disease Treatment Market Forecast
10.4.2 France Autoimmune Disease Treatment Market Forecast
10.4.3 UK Autoimmune Disease Treatment Market Forecast
10.4.4 Italy Autoimmune Disease Treatment Market Forecast
10.4.5 Russia Autoimmune Disease Treatment Market Forecast
10.5 Middle East & Africa Autoimmune Disease Treatment Forecast by Region (2024-2029)
10.5.1 Egypt Autoimmune Disease Treatment Market Forecast
10.5.2 South Africa Autoimmune Disease Treatment Market Forecast
10.5.3 Israel Autoimmune Disease Treatment Market Forecast
10.5.4 Turkey Autoimmune Disease Treatment Market Forecast
10.5.5 GCC Countries Autoimmune Disease Treatment Market Forecast
10.6 Global Autoimmune Disease Treatment Forecast by Type (2024-2029)
10.7 Global Autoimmune Disease Treatment Forecast by Sale Channel (2024-2029)
11 Key Players Analysis
11.1 Abbott Laboratories
11.1.1 Abbott Laboratories Company Information
11.1.2 Abbott Laboratories Autoimmune Disease Treatment Product Offered
11.1.3 Abbott Laboratories Autoimmune Disease Treatment Revenue, Gross Margin and Market Share (2018-2023)
11.1.4 Abbott Laboratories Main Business Overview
11.1.5 Abbott Laboratories Latest Developments
11.2 Active Biotech
11.2.1 Active Biotech Company Information
11.2.2 Active Biotech Autoimmune Disease Treatment Product Offered
11.2.3 Active Biotech Autoimmune Disease Treatment Revenue, Gross Margin and Market Share (2018-2023)
11.2.4 Active Biotech Main Business Overview
11.2.5 Active Biotech Latest Developments
11.3 Eli Lilly
11.3.1 Eli Lilly Company Information
11.3.2 Eli Lilly Autoimmune Disease Treatment Product Offered
11.3.3 Eli Lilly Autoimmune Disease Treatment Revenue, Gross Margin and Market Share (2018-2023)
11.3.4 Eli Lilly Main Business Overview
11.3.5 Eli Lilly Latest Developments
11.4 Bristol-Myers Squibb
11.4.1 Bristol-Myers Squibb Company Information
11.4.2 Bristol-Myers Squibb Autoimmune Disease Treatment Product Offered
11.4.3 Bristol-Myers Squibb Autoimmune Disease Treatment Revenue, Gross Margin and Market Share (2018-2023)
11.4.4 Bristol-Myers Squibb Main Business Overview
11.4.5 Bristol-Myers Squibb Latest Developments
11.5 AstraZeneca plc
11.5.1 AstraZeneca plc Company Information
11.5.2 AstraZeneca plc Autoimmune Disease Treatment Product Offered
11.5.3 AstraZeneca plc Autoimmune Disease Treatment Revenue, Gross Margin and Market Share (2018-2023)
11.5.4 AstraZeneca plc Main Business Overview
11.5.5 AstraZeneca plc Latest Developments
11.6 Pfizer
11.6.1 Pfizer Company Information
11.6.2 Pfizer Autoimmune Disease Treatment Product Offered
11.6.3 Pfizer Autoimmune Disease Treatment Revenue, Gross Margin and Market Share (2018-2023)
11.6.4 Pfizer Main Business Overview
11.6.5 Pfizer Latest Developments
11.7 Biogen Idec
11.7.1 Biogen Idec Company Information
11.7.2 Biogen Idec Autoimmune Disease Treatment Product Offered
11.7.3 Biogen Idec Autoimmune Disease Treatment Revenue, Gross Margin and Market Share (2018-2023)
11.7.4 Biogen Idec Main Business Overview
11.7.5 Biogen Idec Latest Developments
11.8 Lupin Limited
11.8.1 Lupin Limited Company Information
11.8.2 Lupin Limited Autoimmune Disease Treatment Product Offered
11.8.3 Lupin Limited Autoimmune Disease Treatment Revenue, Gross Margin and Market Share (2018-2023)
11.8.4 Lupin Limited Main Business Overview
11.8.5 Lupin Limited Latest Developments
11.9 GlaxoSmithKline
11.9.1 GlaxoSmithKline Company Information
11.9.2 GlaxoSmithKline Autoimmune Disease Treatment Product Offered
11.9.3 GlaxoSmithKline Autoimmune Disease Treatment Revenue, Gross Margin and Market Share (2018-2023)
11.9.4 GlaxoSmithKline Main Business Overview
11.9.5 GlaxoSmithKline Latest Developments
11.10 Amgen
11.10.1 Amgen Company Information
11.10.2 Amgen Autoimmune Disease Treatment Product Offered
11.10.3 Amgen Autoimmune Disease Treatment Revenue, Gross Margin and Market Share (2018-2023)
11.10.4 Amgen Main Business Overview
11.10.5 Amgen Latest Developments
11.11 4SC AG
11.11.1 4SC AG Company Information
11.11.2 4SC AG Autoimmune Disease Treatment Product Offered
11.11.3 4SC AG Autoimmune Disease Treatment Revenue, Gross Margin and Market Share (2018-2023)
11.11.4 4SC AG Main Business Overview
11.11.5 4SC AG Latest Developments
11.12 F. Hoffmann-La Roche Ltd.
11.12.1 F. Hoffmann-La Roche Ltd. Company Information
11.12.2 F. Hoffmann-La Roche Ltd. Autoimmune Disease Treatment Product Offered
11.12.3 F. Hoffmann-La Roche Ltd. Autoimmune Disease Treatment Revenue, Gross Margin and Market Share (2018-2023)
11.12.4 F. Hoffmann-La Roche Ltd. Main Business Overview
11.12.5 F. Hoffmann-La Roche Ltd. Latest Developments
11.13 AutoImmune Inc
11.13.1 AutoImmune Inc Company Information
11.13.2 AutoImmune Inc Autoimmune Disease Treatment Product Offered
11.13.3 AutoImmune Inc Autoimmune Disease Treatment Revenue, Gross Margin and Market Share (2018-2023)
11.13.4 AutoImmune Inc Main Business Overview
11.13.5 AutoImmune Inc Latest Developments
11.14 Johnson & Johnson
11.14.1 Johnson & Johnson Company Information
11.14.2 Johnson & Johnson Autoimmune Disease Treatment Product Offered
11.14.3 Johnson & Johnson Autoimmune Disease Treatment Revenue, Gross Margin and Market Share (2018-2023)
11.14.4 Johnson & Johnson Main Business Overview
11.14.5 Johnson & Johnson Latest Developments
11.15 Bayer
11.15.1 Bayer Company Information
11.15.2 Bayer Autoimmune Disease Treatment Product Offered
11.15.3 Bayer Autoimmune Disease Treatment Revenue, Gross Margin and Market Share (2018-2023)
11.15.4 Bayer Main Business Overview
11.15.5 Bayer Latest Developments
12 Research Findings and Conclusion
*If Applicable.